Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Netstreit | NTST | Nov 26, 2024 | 16.22 | -0.49 |
Network-1 Technologies | NTIP | Nov 26, 2024 | 1.33 | -0.75 |
Neuberger Berman | NML | Nov 26, 2024 | 9.24 | -0.32 |
Neuberger Berman High Yield Strategies Fund | NHS | Nov 26, 2024 | 7.74 | -0.51 |
Neuberger Berman Municipal Fund | NBH | Nov 26, 2024 | 10.73 | -0.19 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | Nov 26, 2024 | 13.16 | +0.23 |
Neuberger Berman Real Estate Securities Income Fund | NRO | Nov 26, 2024 | 3.84 | -0.52 |
NeueHealth | NEUE | Nov 26, 2024 | 4.90 | +0.82 |
Neumora Therapeutics | NMRA | Nov 26, 2024 | 9.77 | +1.03 |
Neuraxis | NRXS | Nov 26, 2024 | 3.06 | +0.83 |
Neurobo Pharmaceuticals | NRBO | Nov 26, 2024 | 2.35 | -2.89 |
Neurocrine Biosciences | NBIX | Nov 26, 2024 | 127.91 | +0.63 |
Neurogene | NGNE | Nov 26, 2024 | 26.87 | +20.41 |
NeuroMetrix | NURO | Nov 26, 2024 | 4.25 | +0.64 |
Neuronetics | STIM | Nov 26, 2024 | 0.95 | -1.66 |
NeuroOne | NMTC | Nov 26, 2024 | 0.70 | +13.74 |
Neuropace | NPCE | Nov 26, 2024 | 10.20 | -4.32 |
NeuroSense Therapeutics | NRSN | Nov 26, 2024 | 0.90 | +2.57 |
Nevro | NVRO | Nov 26, 2024 | 4.32 | -5.05 |
New America High Income Fund | HYB | Nov 26, 2024 | 8.27 | +0.61 |
New Concept Energy | GBR | Nov 26, 2024 | 1.22 | +3.39 |
New England Realty Associates LP Unit A | NEN | Nov 26, 2024 | 82.49 | 0.00 |
New Fortress Energy A | NFE | Nov 26, 2024 | 10.04 | +3.40 |
New Found Gold | NFGC | Nov 26, 2024 | 1.66 | +0.61 |
New Germany Fund | GF | Nov 26, 2024 | 8.03 | +0.12 |
New Gold | NGD | Nov 26, 2024 | 2.71 | +1.88 |
New Horizon Aircraft | HOVR | Nov 26, 2024 | 0.52 | +2.37 |
New Mountain Finance Corp | NMFC | Nov 26, 2024 | 11.82 | +0.17 |
New Oriental Education & Technology Group ADR | EDU | Nov 26, 2024 | 58.58 | -0.36 |
New Pacific Metals | NEWP | Nov 26, 2024 | 1.64 | +4.14 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.